Cytokine analyses demonstrated alterations in circulating inflammatory and remodeling markers; however, predictive modeling indicated that these alone had limited discriminatory performance. Model accuracy improved when variables were integrated with clinical and imaging metrics, suggesting a subset of circulating proteins contributes to disease pathways. Lipidomic profiling revealed distinct remodeling of inflammatory lipid mediator pathways, with clear separation between FA and control driven by coordinated pathway-level changes. Mass spec proteomics and early single-cell immune profiling further identified trends consistent with mitochondrial stress, immune activation, and fibro-inflammatory signaling.